Unknown PHASE4 INTERVENTIONAL 1-arm NCT03274284

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer After BCG Failure

Sponsor: Assiut University

Updated 6 times since 2017 Last updated: Sep 6, 2017 Started: Oct 31, 2017 Primary completion: Nov 30, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bladder Cancer and is currently ongoing. Assiut University leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jan 2020 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.